Structural basis of a shared antibody response to SARS-CoV-2.
Yuan, M., Liu, H., Wu, N.C., Lee, C.D., Zhu, X., Zhao, F., Huang, D., Yu, W., Hua, Y., Tien, H., Rogers, T.F., Landais, E., Sok, D., Jardine, J.G., Burton, D.R., Wilson, I.A.(2020) Science 369: 1119-1123
- PubMed: 32661058 
- DOI: https://doi.org/10.1126/science.abd2321
- Primary Citation of Related Structures:  
6XC2, 6XC3, 6XC4, 6XC7 - PubMed Abstract: 
Molecular understanding of neutralizing antibody responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) could accelerate vaccine design and drug discovery. We analyzed 294 anti-SARS-CoV-2 antibodies and found that immunoglobulin G heavy-chain variable region 3-53 (IGHV3-53) is the most frequently used IGHV gene for targeting the receptor-binding domain (RBD) of the spike protein ...